Rodgers Richard J
Insider CIK 1313397 · NVAX Director · RNN Interim CEO and President, Director · SGMT Director · ARDX Director · TSRO Executive VP & CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVAX NOVAVAX INC | M Exercise deriv | 2026-06-20 | 2026-06-23 | 18,880 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2026-06-20 | 2026-06-23 | 18,880 | — | $0 | 47,370 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-06-18 | 2026-06-23 | 14,180 | — | $0 | 14,180 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-06-18 | 2026-06-23 | 21,270 | — | $0 | 21,270 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2026-06-16 | 2026-06-18 | 39,715 | — | $0 | 39,715 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2026-06-16 | 2026-06-18 | 26,455 | — | $0 | 439,998 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2026-04-20 | 2026-04-22 | 24,367 | — | $0 | 343,022 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2025-10-29 | 2025-10-30 | 3,800 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2025-10-29 | 2025-10-30 | 3,800 | — | $0 | 28,490 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-06-20 | 2025-06-24 | 18,884 | — | $0 | 18,884 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-06-20 | 2025-06-24 | 28,326 | $6.42 | $181.9K | 28,326 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2025-06-18 | 2025-06-23 | 54,059 | — | $0 | 54,059 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2025-06-18 | 2025-06-23 | 21,468 | — | $0 | 371,992 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2025-06-18 | 2025-06-23 | 41,551 | — | $0 | 413,543 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2025-06-12 | 2025-06-13 | 10,420 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2025-06-12 | 2025-06-13 | 10,420 | — | $0 | 24,690 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award deriv | 2025-04-30 | 2025-05-02 | 79,592 | — | $0 | 79,592 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2025-04-30 | 2025-05-02 | 79,504 | — | $0 | 318,655 | SEC↗ |
| ARDX ARDELYX, INC. | M Exercise deriv | 2025-01-16 | 2025-01-17 | 100,000 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | M Exercise | 2025-01-16 | 2025-01-17 | 100,000 | $0.55 | $55.0K | 350,524 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2024-10-29 | 2025-01-02 | 3,800 | — | $0 | 3,800 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2024-10-29 | 2025-01-02 | 3,800 | — | $0 | 14,270 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2024-06-14 | 2024-06-17 | 40,243 | — | $0 | 40,243 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2024-06-14 | 2024-06-17 | 12,204 | — | $0 | 250,524 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2024-06-12 | 2024-06-14 | 10,420 | — | $0 | 10,420 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2024-06-12 | 2024-06-14 | 6,670 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2024-06-12 | 2024-06-14 | 15,630 | $15.86 | $247.9K | 15,630 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2024-06-12 | 2024-06-14 | 6,670 | — | $0 | 10,470 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 35,181 | — | $0 | 35,181 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2024-06-11 | 2024-06-13 | 41,143 | — | $0 | 239,151 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2024-01-01 | 2024-01-03 | 24,762 | — | $0 | 198,008 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2023-11-01 | 2023-11-13 | 35,000 | — | $0 | 173,246 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2023-10-29 | 2023-10-31 | 3,800 | — | $0 | 7,600 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2023-10-29 | 2023-10-31 | 3,800 | — | $0 | 3,800 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | D To issuer deriv | 2023-07-18 | 2023-07-20 | 1,976 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | A Award deriv | 2023-07-18 | 2023-07-20 | 23,216 | — | $0 | 23,216 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | A Award deriv | 2023-07-18 | 2023-07-20 | 1,976 | — | $0 | 1,976 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | D To issuer deriv | 2023-07-18 | 2023-07-20 | 23,216 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | A Award deriv | 2023-07-18 | 2023-07-20 | 23,839 | — | $0 | 23,839 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | D To issuer deriv | 2023-07-18 | 2023-07-20 | 23,839 | — | $0 | 0 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2023-06-15 | 2023-06-16 | 49,237 | — | $0 | 49,237 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2023-06-15 | 2023-06-16 | 18,494 | — | $0 | 238,320 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-06-12 | 2023-06-13 | 6,670 | — | $0 | 6,670 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-06-12 | 2023-06-13 | 7,710 | — | $0 | 7,710 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2023-04-19 | 2023-04-21 | 50,000 | — | $0 | 138,246 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2023-01-11 | 2023-01-12 | 20,822 | — | $0 | 88,246 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-10-29 | 2022-11-01 | 11,400 | — | $0 | 11,400 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-10-29 | 2022-11-01 | 17,095 | — | $0 | 17,095 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | X Exercise deriv | 2022-10-03 | 2022-10-04 | 3,148 | — | $0 | 0 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | X Exercise | 2022-10-03 | 2022-10-04 | 3,148 | — | $0 | 67,424 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2022-07-01 | 2022-07-06 | 15,841 | — | $0 | 64,276 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2022-07-01 | 2022-07-06 | 7,812 | — | $0 | 48,435 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2022-06-15 | 2022-06-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2022-06-15 | 2022-06-17 | 132,299 | — | $0 | 219,826 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2022-04-01 | 2022-04-05 | 4,629 | — | $0 | 40,623 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2022-01-03 | 2022-01-05 | 4,021 | — | $0 | 35,994 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2021-10-01 | 2021-10-04 | 2,912 | — | $0 | 31,973 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2021-07-01 | 2021-07-02 | 2,840 | — | $0 | 29,061 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2021-06-16 | 2021-06-21 | 32,765 | — | $0 | 32,765 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2021-06-16 | 2021-06-21 | 9,917 | — | $0 | 87,527 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2021-06-07 | 2021-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2021-04-01 | 2021-04-05 | 2,581 | — | $0 | 26,221 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy deriv | 2020-11-19 | 2020-11-25 | 3,148 | — | $0 | 3,148 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy deriv | 2020-11-19 | 2020-11-25 | 26,789 | — | $0 | 26,789 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy | 2020-11-19 | 2020-11-25 | 17,730 | — | $0 | 23,640 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2020-11-11 | 2020-11-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2020-11-05 | 2020-11-09 | 5,910 | — | $0 | 5,910 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2020-06-09 | 2020-06-11 | 23,500 | — | $0 | 23,500 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2020-06-09 | 2020-06-11 | 9,233 | — | $0 | 77,610 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2019-06-13 | 2019-06-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2019-06-13 | 2019-06-17 | 24,635 | — | $0 | 68,377 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2019-06-06 | 2019-06-07 | 3,537 | — | $0 | 3,537 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2018-06-28 | 2018-06-29 | 39,742 | — | $0 | 39,742 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2018-06-13 | 2018-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2018-06-13 | 2018-06-15 | 16,749 | — | $0 | 43,742 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2017-06-07 | 2017-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2017-06-07 | 2017-06-09 | 15,697 | — | $0 | 26,993 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2017-04-11 | 2017-04-12 | 110,000 | — | $0 | 110,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2016-06-09 | 2016-06-10 | 225,000 | — | $0 | 225,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2016-06-02 | 2016-06-06 | 6,742 | — | $0 | 11,296 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2015-09-16 | 2015-09-18 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2015-06-11 | 2015-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2015-06-11 | 2015-06-12 | 4,554 | — | $0 | 4,554 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2014-12-02 | 2014-12-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2014-06-18 | 2014-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2013-03-06 | 2013-03-08 | 65,000 | — | $0 | 65,000 | SEC↗ |
| TSRO TESARO, Inc. | C Conversion deriv | 2012-07-03 | 2012-07-06 | 250,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | C Conversion | 2012-07-03 | 2012-07-06 | 71,428 | — | $0 | 257,141 | SEC↗ |